Weekly Newsletter Signup | Vendors, CIO Viewpoint, CXO Insights
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Weekly Brief

Subscribe

Weekly Brief

Thursday, February 2,2023

Feature of the Week

The human microbiome is acknowledged as a significant contributor to health and disease.  Read more
"We've deepened our bench of experts by adding some of the most experienced REMS professionals to our team, including Melissa Landers," says Howard Miller,  Read more
Contract manufacturing organizations (CMO) can deliver many important benefits when bringing a new product to market.  Read more

CIO Viewpoint

By Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE]  
Business Technology has developed a scalable cloud architecture leveraging best-in-class agile technologies for clinical data management and analytics.  Read more
By William Jason Cole, CIO, Meritus Health  
As we look to broaden the toolbox used to improve overall health for the population we serve, wearables undoubtably have a firm place in healthcare  Read more

Featured Vendors

By David Hahn, Worldwide Head  
TMAC is a U.S.-based company providing life sciences clients with a wide array of tailored outsourcing capabilities for global medical affairs activities. It offers both strategic and tactical medical science liaison support services in addition...  Read more
By Catherine Baldridge, Head of Safety Affairs, Sid Senroy, Founder & President  
RegDev, Inc provides services for meeting the unique needs of multinational clients in the biopharmaceutical industry. Their team of highly experienced and committed consultants is dedicated to delivering quality services that enhance value for...  Read more

CXO Insights

By Kelly H. Zou, PhD, PStat, FASA, Head of Global Medical Analytics and Real World Evidence, Viatris  
According to the 21st Century Cures Act, the United States (US) Congress defined RWE as data regarding...  Read more
By Matthew Hewitt, Executive Director, Scientific Solutions C and GT, Charles River  
Matthew (Matt) Hewitt, a leader in the cell and gene therapy field, joined Charles River in 2021 as...  Read more